Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotides

Journal of Immunotherapy

Volumn 26, Issue 4, 2003, Pages 313-319

  Leifer, Cynthia A ^a   Verthelyi, Daniela ^a   Klinman, Dennis M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

CpG oligonucleotides; Cytokines; Heterogeneity; Human PBMC; Immune response; Immunoglobulin

Indexed keywords

IMMUNOGLOBULIN M; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE;

ADULT; AGED; ARTICLE; CELL HETEROGENEITY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

B-LYMPHOCYTES; CELL DIVISION; CLINICAL TRIALS; CPG ISLANDS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; OLIGONUCLEOTIDES;

EID: 0037829434     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200307000-00003     Document Type: Article

References (25)

1. Yamamoto S, Yamamoto T, Shimada S, et al. DNA from bacteria, but not vertebrates, induces interferons, activate NK cells and inhibits tumor growth. Microbiol Immunol. 1992;36:983-997.
2. Messina JP, Gilkeson GS, Pisetsky DS. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 1991;147:1759-1764.
3. Krieg AM, Yi A, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374:546-548.
4. Sparwasser T, Koch E, Vabulas RM, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol. 1998;28:2045-2054.
5. Klinman DM, Yi A, Beaucage SL, et al. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNγ. Proc Natl Acad Sci USA. 1996;93:2879-2883.
6. Yamamoto S, Yamamoto T, Katoaka T, et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol. 1992;148:4072-4076.
7. Klinman DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine. 1999;17:19-25.
8. Sur S, Wild JS, Choudhury BK, et al. Long-term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol. 1999;162:6284-6291.
9. Elkins KL, Rhinehart-Jones TR, Stibitz S, et al. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol. 1999;162:2291-2298.
10. Weiner GJ, Liu HM, Wooldridge JE, et al. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Nat Acad Sci USA. 1997;94:10833-10837.
11. Bauer M, Heeg K, Wagner H, et al. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology. 1999;97:699-705.
12. Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol. 2000;164:944-952.
13. Verthelyi D, Ishii KJ, Gursel M, et al. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol. 2001;166:2372-2377.
14. Roman M, Martin-Orozco E, Goodman JS, et al. Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nat Medicine. 1997;3:849-854.
15. Liang H, Nishioka Y, Reich CF, et al. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest. 1996;98:1119-1129.
16. Sester DP, Naik S, Beasley J, et al. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J Immunol. 2000;165:4165-4173.
17. McCluskie MJ, Davis HL. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine. 2000;19:413-422.
18. Lipford GB, Bauer M, Blank C, et al. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol. 1997;27:2340-2344.
19. Kline JN, Waldschmidt TJ, Businga TR, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol. 1998;160:2555-2559.
20. Davis HL, Weeranta R, Waldschmidt TJ, et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 1998;160:870-876.
21. Bohle B, Orel L, Kraft D, et al. Oligodeoxynucleotides containing CpG motifs induce low levels of TNF-alpha in human B lymphocytes: possible adjuvants for Th1 responses. J Immunol. 2001;166:3743-3748.
22. Hartmann G, Weeratna RD, Ballas ZK, et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol. 2000;164:1617-1624.
23. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740-745.
24. Takeshita F, Leifer CA, Gursel I, et al. Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol. 2001;167:3555-3558.
25. Bauer S, Kirschning CJ, Hacker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Nat Acad Sci USA. 2001;98:9237-9242.